NCT07528586 2026-04-14
CMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Phase NA Recruiting
Clinical Trials
37 trialsNCT06183437 2026-03-30
STOP-MED CTRCD
University Health Network, Toronto
Phase 4 Recruiting
NCT06778122 2026-03-27
BREATHS
University College, London
Phase NA Recruiting
NCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
NCT06443645 2026-02-04
SCARA-B
Centre Paul Strauss
Recruiting
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
NCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07299812 2025-12-23
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT05023785 2025-11-26
HIMALAYAS
University Health Network, Toronto
Phase NA Recruiting
NCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT06350994 2025-09-02
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT06132984 2025-08-01
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
West China Second University Hospital
Recruiting
NCT02772367 2025-07-16
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Recruiting
NCT06310330 2025-06-06
TRUST-ACE
Norwegian University of Science and Technology
Phase NA Recruiting
NCT03790943 2025-05-07
Cardio-Onco
University of Bern
Recruiting
NCT05406635 2025-04-08
HER2BIC
Odense University Hospital
Phase NA Recruiting
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT06664528 2025-03-04
CV_CANCER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT04262830 2025-01-28
CATCH-HF
University of California, San Diego
Recruiting
NCT03934905 2024-11-20
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Texas Tech University Health Sciences Center
Phase 1/2 Recruiting
NCT05703126 2024-11-05
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Samara State Medical University
Phase NA Recruiting
NCT06622954 2024-10-02
PROTECT-COR
Erasmus Medical Center
Phase NA Recruiting
NCT05851053 2024-05-29
BLOC-II
University Medical Center Groningen
Recruiting
NCT05467111 2024-04-11
CardioProtEx
Technical University of Madrid
Phase NA Recruiting
NCT06340516 2024-04-01
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
Vastra Gotaland Region
Phase NA Recruiting
NCT06270667 2024-03-22
LYMfit
Norwegian School of Sport Sciences
Phase NA Recruiting
NCT06282796 2024-02-28
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
First Hospital of China Medical University
Recruiting
NCT06214195 2024-01-19
START
Zhejiang Cancer Hospital
Phase 3 Recruiting
NCT05258448 2023-12-06
COLA
Odense University Hospital
Recruiting
NCT05921279 2023-07-25
UCARE
National University of Ireland, Galway, Ireland
Recruiting
NCT05732051 2023-03-17
NARNIA
University Hospital, Akershus
Phase 2 Recruiting
NCT05598879 2022-10-28
G-COR
The Cleveland Clinic
Recruiting
NCT04822077 2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA Recruiting